NR3C2 and cancer: The potential of this receptor in cancer therapy is still unexplored, and the use of MR inhibitors or MR antibody-decorated NPs or cell membranes with MR expression coating drug NPs can be used to target gastric cancer or reduce viral titers by blocking MR and releasing antiviral drugs in a CMCNP-based approach.